Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 4
Submit an article Journal homepage
514
Views
8
CrossRef citations to date
0
Altmetric
Original Article: Clinical

A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma

Greg HapgoodDepartment of Haematology, Princess Alexandra Hospital, Brisbane, Australia; View further author information
,
Janey M. StoneAustralasian Leukaemia and Lymphoma Group, Melbourne, Australia; View further author information
,
Diana ZanninoAustralasian Leukaemia and Lymphoma Group, Melbourne, Australia; View further author information
,
Anup GeorgeWellington Blood and Cancer Centre, Wellington Regional Hospital, Wellington, New Zealand; View further author information
,
Paula MarltonDepartment of Haematology, Princess Alexandra Hospital, Brisbane, Australia; ;School of Medicine University of Queensland, Brisbane, Australia; View further author information
,
Henry Miles PrinceEpworth Healthcare and Peter MacCallum, Department of Oncology, University of Melbourne, Melbourne, Australia; View further author information
,
Chi-Hung HuiDepartment of Haematology, Adelaide Cancer Centre, Adelaide, Australia; View further author information
,
Ian ProsserDepartment of Haematology, Canberra Hospital, Canberra, Australia; View further author information
,
Ian D. LewisFaculty of Health & Medical Sciences, Department of Haematology, Royal Adelaide Hospital, University of Adelaide, Adelaide, Australia; View further author information
,
Kenneth BradstockDepartment of Haematology, Westmead Hospital, Sydney, Australia; View further author information
,
John F. SeymourDepartment of Haematology, Peter MacCallum Cancer Centre, Melbourne, AustraliaCorrespondence[email protected]
View further author information
& On behalf of the Australasian Leukaemia and Lymphoma Group show all
Pages 904-911 | Received 19 May 2018, Accepted 21 Aug 2018, Published online: 14 Dec 2018

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

James A. Kuzich, Andrew P. Hutchison, Kenneth J. C. Lim, Portia Smallbone, Kate Denning, Matthew P. Wright, Gavin Cull, Michael F. Leahy, David J. L. Joske, Dejan Radeski & Duncan Purtill. (2019) Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of ‘real-world’ experience from Western Australia. Leukemia & Lymphoma 60:14, pages 3417-3425.
Read now

Articles from other publishers (7)

Vibor Milunović, Inga Mandac Smoljanović, Martina Bogeljić Patekar, Viktor Zatezalo, Marin Kursar, Delfa Radić-Krišto, Slobodanka Ostojić Kolonić & Slavko Gašparov. (2023) First-Line Therapy for Nodal T-cell Non-Hodgkin Lymphomas: an Unmet Need in Hematology. Current Oncology Reports 25:7, pages 813-824.
Crossref
Greg Hapgood, Maya Latimer, Sze Ting Lee, Bryone Kuss, Stephen Lade, Joshua W. D. Tobin, Duncan Purtill, Belinda A. Campbell, H. Miles Prince, Eliza A. Hawkes, Jake Shortt & Dejan Radeski. (2022) Diagnosis, management and follow up of peripheral T‐cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal 52:10, pages 1806-1817.
Crossref
David Sibon. (2022) Peripheral T-Cell Lymphomas: Therapeutic Approaches. Cancers 14:9, pages 2332.
Crossref
Kristina Sonnevi, Maria Ljungqvist, Jóel Kristinn Jóelsson, Sara Harrysson, Tove Wästerlid, Per Bernell & Björn Engelbrekt Wahlin. (2021) Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience. eJHaem 2:4, pages 774-784.
Crossref
Kitsada Wudhikarn & N. Nora Bennani. (2021) How to Sequence Therapies in Peripheral T Cell Lymphoma. Current Treatment Options in Oncology 22:9.
Crossref
Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, Amit Khot, Michael Dickinson, Costas K. Yannakou & H. Miles Prince. (2021) Advances in Frontline Management of Peripheral T-cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 21:6, pages 368-378.
Crossref
Stefan K. BartaJerald Z. Gong & Pierluigi Porcu. (2019) Brentuximab vedotin in the treatment of CD30+ PTCL. Blood 134:26, pages 2339-2345.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.